Kate A Scott

Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.

Chris J. Scotton, Julia L. Wilson, Kate A Scott et al. · PubMed · 2002 · 479 citations

A chemokine receptor antagonist inhibits experimental breast tumor growth.

Stephen C. Robinson, Kate A Scott, Julia L. Wilson et al. · PubMed · 2003 · 258 citations

Breast Oncology, Chemokine Biology, Immunology +16

Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development

Caroline H. Arnott, Kate A Scott, Robert J. Moore et al. · Oncogene · 2003 · 205 citations

Cancer Research, Skin Development, Cutaneous Biology +13

Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway

Caroline H. Arnott, Kate A Scott, Robert J. Moore et al. · Oncogene · 2002 · 165 citations

Inflammation, Cancer Research, Signal Transduction +11

An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.

Kate A Scott, Robert J. Moore, Caroline H. Arnott et al. · PubMed · 2003 · 150 citations

Immunology, Pathology, Tpa-stimulated Expression +16